<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="case-report" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Genomics Insights</journal-id>
<journal-id journal-id-type="iso-abbrev">Genomics Insights</journal-id>
<journal-id journal-id-type="publisher-id">GEN</journal-id>
<journal-id journal-id-type="hwp">spgen</journal-id>
<journal-title-group>
<journal-title>Genomics Insights</journal-title>
</journal-title-group>
<issn pub-type="epub">1178-6310</issn>
<publisher>
<publisher-name>SAGE Publications</publisher-name>
<publisher-loc>Sage UK: London, England</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">31043788</article-id>
<article-id pub-id-type="pmc">6446253</article-id>
<article-id pub-id-type="doi">10.1177/1178631019839010</article-id>
<article-id pub-id-type="publisher-id">10.1177_1178631019839010</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Case Report</subject>
</subj-group>
</article-categories>
<title-group>
<article-title><italic>De Novo</italic> Duplication in the <italic>CHD7</italic> Gene Associated With Severe CHARGE Syndrome</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Pranckėnienė</surname>
<given-names>Laura</given-names>
</name>
<xref ref-type="aff" rid="aff1-1178631019839010">1</xref>
<xref ref-type="corresp" rid="corresp1-1178631019839010"></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Preikšaitienė</surname>
<given-names>Eglė</given-names>
</name>
<xref ref-type="aff" rid="aff1-1178631019839010">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Gueneau</surname>
<given-names>Lucie</given-names>
</name>
<xref ref-type="aff" rid="aff2-1178631019839010">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Reymond</surname>
<given-names>Alexandre</given-names>
</name>
<xref ref-type="aff" rid="aff2-1178631019839010">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kučinskas</surname>
<given-names>Vaidutis</given-names>
</name>
<xref ref-type="aff" rid="aff1-1178631019839010">1</xref>
</contrib>
</contrib-group>
<aff id="aff1-1178631019839010"><label>1</label>Department of Human and Medical Genetics, Faculty of Medicine, Institute of Biomedical Sciences, Vilnius University, Vilnius, Lithuania</aff>
<aff id="aff2-1178631019839010"><label>2</label>Center for Integrative Genomics, Faculty of Biology and Medicine, University of Lausanne, Lausanne, Switzerland</aff>
<author-notes>
<corresp id="corresp1-1178631019839010">Laura Pranckėnienė, Department of Human and Medical Genetics, Faculty of Medicine, Institute of Biomedical Sciences, Vilnius University, Vilnius 01513, Lithuania. Email: <email>Laura.pranckeniene@mf.vu.lt</email></corresp>
</author-notes>
<pub-date pub-type="epub">
<day>02</day>
<month>4</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="collection">
<year>2019</year>
</pub-date>
<volume>12</volume>
<elocation-id>1178631019839010</elocation-id>
<history>
<date date-type="received">
<day>22</day>
<month>1</month>
<year>2019</year>
</date>
<date date-type="accepted">
<day>28</day>
<month>2</month>
<year>2019</year>
</date>
</history>
<permissions>
<copyright-statement>© The Author(s) 2019</copyright-statement>
<copyright-year>2019</copyright-year>
<copyright-holder content-type="sage">SAGE Publications Ltd unless otherwise noted. Manuscript content on this site is licensed under Creative Commons Licenses</copyright-holder>
<license license-type="creative-commons" xlink:href="http://www.creativecommons.org/licenses/by-nc/4.0/">
<license-p>This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (<ext-link ext-link-type="uri" xlink:href="http://www.creativecommons.org/licenses/by-nc/4.0/">http://www.creativecommons.org/licenses/by-nc/4.0/</ext-link>) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (<ext-link ext-link-type="uri" xlink:href="https://us.sagepub.com/en-us/nam/open-access-at-sage">https://us.sagepub.com/en-us/nam/open-access-at-sage</ext-link>).</license-p>
</license>
</permissions>
<abstract>
<p>CHARGE syndrome is an autosomal dominant developmental disorder associated with a constellation of traits involving almost every organ and sensory system, in particular congenital anomalies, including choanal atresia and malformations of the heart, inner ear, and retina. Variants in <italic>CHD7</italic> have been shown to cause CHARGE syndrome. Here, we report the identification of a novel <italic>de novo</italic> p.Asp2119_Pro2120ins6 duplication variant in a conserved region of <italic>CHD7</italic> in a severely affected boy presenting with 3 and 5 of the CHARGE cardinal major and minor signs, respectively, combined with congenital umbilical hernia, congenital hernia at the linea alba, mildly hypoplastic inferior vermis, slight dilatation of the lateral ventricles, prominent metopic ridge, and hypoglycemic episodes.</p>
</abstract>
<kwd-group>
<kwd>Intellectual disability</kwd>
<kwd>CHARGE syndrome</kwd>
<kwd>
<italic>CHD7</italic>
</kwd>
<kwd><italic>de novo</italic> variant</kwd>
<kwd>WES</kwd>
</kwd-group>
<funding-group>
<award-group id="award1-1178631019839010">
<funding-source id="funding1-1178631019839010">
<institution-wrap>
<institution>schweizerischer nationalfonds zur förderung der wissenschaftlichen forschung</institution>
<institution-id institution-id-type="FundRef">https://doi.org/10.13039/501100001711</institution-id>
</institution-wrap>
</funding-source>
<award-id rid="funding1-1178631019839010">31003A_160203</award-id>
</award-group>
<award-group id="award2-1178631019839010">
<funding-source id="funding2-1178631019839010">
<institution-wrap>
<institution>Lithuanian-Swiss cooperation program</institution>
<institution-id></institution-id>
</institution-wrap>
</funding-source>
<award-id rid="funding2-1178631019839010">CH-3-ŠMM-01/04</award-id>
</award-group>
</funding-group>
<custom-meta-group>
<custom-meta>
<meta-name>cover-date</meta-name>
<meta-value>January-December 2019</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
<body>
<sec id="section1-1178631019839010" sec-type="intro">
<title>Introduction</title>
<p>CHARGE syndrome (MIM 214800) is a multifaceted condition affecting between 1 in 8500 and 1 in 17 000 individuals.<sup><xref ref-type="bibr" rid="bibr1-1178631019839010">1</xref></sup> The acronym CHARGE was established based on the combination of patients’ phenotypes, such as coloboma, heart defect, atresia choanae (also known as choanal atresia), retardation of growth and/or development, genital defects, ear anomalies, and/or deafness in patients. All malformations related to CHARGE syndrome occur early in the first trimester of pregnancy, while growth and developmental retardation become more obvious as the child matures. In some patients, clinical phenotype overlaps with those described for other syndromes, such as DiGeorge syndrome, velocardiofacial, oculo-auriculo-vertebral, and Kallmann syndromes.<sup><xref ref-type="bibr" rid="bibr2-1178631019839010">2</xref>,<xref ref-type="bibr" rid="bibr3-1178631019839010">3</xref></sup> Clinical diagnosis is made with a set of criteria (<xref ref-type="table" rid="table1-1178631019839010">Table 1</xref>) and CHARGE patients typically have all 4 major or 3 major and 3 minor features, while individuals suspected to have CHARGE syndrome may only have 1 or 2 major and several minor characteristics. Subsequent molecular confirmation enables genetic counselling concerning recurrence risk.</p>
<table-wrap id="table1-1178631019839010" orientation="portrait" position="float">
<label>Table 1.</label>
<caption>
<p>Major and minor diagnostic characteristics of CHARGE syndrome and phenotype of the proband.<sup><xref ref-type="bibr" rid="bibr3-1178631019839010">3</xref></sup></p>
</caption>
<alternatives>
<graphic xlink:href="10.1177_1178631019839010-table1"></graphic>
<table frame="hsides" rules="groups">
<colgroup span="1">
<col align="left" span="1"/>
<col align="char" char="." span="1"/>
<col align="char" char="." span="1"/>
<col align="char" char="." span="1"/>
</colgroup>
<thead>
<tr>
<th align="left" colspan="1" rowspan="1">Characteristics</th>
<th align="left" colspan="1" rowspan="1">Manifestations</th>
<th align="left" colspan="1" rowspan="1">Frequency</th>
<th align="left" colspan="1" rowspan="1">Proband</th>
</tr>
</thead>
<tbody>
<tr>
<td colspan="4" rowspan="1">
<italic>Major diagnostic characteristics</italic>
</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Ocular coloboma</td>
<td colspan="1" rowspan="1">Coloboma of the iris, retina, choroid, disc; microphthalmia</td>
<td colspan="1" rowspan="1">80%–90%</td>
<td colspan="1" rowspan="1">• Bilateral choroid coloboma involving optic nerve</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Choanal atresia or stenosis</td>
<td colspan="1" rowspan="1">Unilateral/bilateral: bony or membranous atresia/stenosis</td>
<td colspan="1" rowspan="1">50%–60%</td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td colspan="1" rowspan="1">Cranial nerve dysfunction or anomaly</td>
<td colspan="1" rowspan="1">I: hyposmia or anosmia</td>
<td colspan="1" rowspan="1">Frequent</td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1">VII: facial palsy (unilateral or bilateral)</td>
<td colspan="1" rowspan="1">&gt;40%</td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1">VIII: hypoplasia of auditory nerve</td>
<td colspan="1" rowspan="1">Frequent</td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1">IX/X: swallowing problems with aspiration</td>
<td colspan="1" rowspan="1">70%–90%</td>
<td colspan="1" rowspan="1">• Swallowing problems</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Ear</td>
<td colspan="1" rowspan="1">Outer ear: short, wide ear with little or no lobe, ‘snipped off’ helix, prominent antihelix that is often discontinuous with tragus, triangular concha, decreased cartilage; often protruding and usually asymmetric;<break></break>Middle ear: ossicular malformations;<break></break>Mondini defect of the cochlea;<break></break>Temporal bone abnormalities; absent or hypoplastic semicircular canals</td>
<td colspan="1" rowspan="1">80%–100%</td>
<td colspan="1" rowspan="1">• Smaller and wide right ear<break></break>• Bilateral sensorineural hearing loss</td>
</tr>
<tr>
<td colspan="4" rowspan="1">
<italic>Minor diagnostic characteristics</italic>
</td>
</tr>
<tr>
<td colspan="1" rowspan="2">Genital hypoplasia</td>
<td colspan="1" rowspan="1">Males: micropenis, cryptorchidism<break></break>Females: hypoplastic labia</td>
<td colspan="1" rowspan="1">50%–60%</td>
<td colspan="1" rowspan="1">• Micropenis, cryptorchidism</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Males and females: delayed puberty secondary to hypogonadotropic hypogonadism</td>
<td colspan="1" rowspan="1">Frequent</td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td colspan="1" rowspan="1">Developmental delay</td>
<td colspan="1" rowspan="1">Delayed milestones, hypotonia</td>
<td colspan="1" rowspan="1">Almost 100%</td>
<td colspan="1" rowspan="1">• Delayed psychomotor development<break></break>• Autism spectrum disorder</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Cardiovascular malformation</td>
<td colspan="1" rowspan="1">Including conotruncal defects (eg, tetralogy of Fallot), AV canal defects, and aortic arch anomalies</td>
<td colspan="1" rowspan="1">75%–85%</td>
<td colspan="1" rowspan="1">• Small atrial septal defect</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Growth deficiency</td>
<td colspan="1" rowspan="1">Short stature, usually postnatal with or without growth hormone deficiency</td>
<td colspan="1" rowspan="1">70%–80%</td>
<td colspan="1" rowspan="1">• Weight and height &lt;3rd centile</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Orofacial cleft</td>
<td colspan="1" rowspan="1">Cleft lip and/or palate</td>
<td colspan="1" rowspan="1">15%–20%</td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td colspan="1" rowspan="1">Tracheoesophageal (TE) fistula</td>
<td colspan="1" rowspan="1">TE defects of all types</td>
<td colspan="1" rowspan="1">15%–20%</td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td colspan="1" rowspan="1">Distinctive facial features</td>
<td colspan="1" rowspan="1">Square face with broad prominent forehead, prominent nasal bridge and columella, flat midface</td>
<td colspan="1" rowspan="1">70%–80%</td>
<td colspan="1" rowspan="1">• Prominent forehead, prominent metopic ridge</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Other features</td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1">• Congenital umbilical hernia and congenital hernia at the linea alba;<break></break>• Mildly hypoplastic inferior vermis and slight dilatation of the lateral ventricles;<break></break>• Hypoglycemic episodes</td>
</tr>
</tbody>
</table>
</alternatives>
<table-wrap-foot>
<fn id="table-fn1-1178631019839010">
<p>Abbreviation: AV, atreoventricular.</p>
</fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="section2-1178631019839010" sec-type="methods">
<title>Methods</title>
<sec id="section3-1178631019839010">
<title>Whole exome sequencing</title>
<p>DNA was extracted from peripheral blood lymphocytes using the phenol-chloroform extraction method. The proband and his healthy parents were assessed by whole exome sequencing (WES). We followed the procedure we routinely and successfully used to identify the cause of Mendelian diseases.<sup><xref ref-type="bibr" rid="bibr4-1178631019839010">4</xref><xref ref-type="bibr" rid="bibr5-1178631019839010"></xref><xref ref-type="bibr" rid="bibr6-1178631019839010"></xref><xref ref-type="bibr" rid="bibr7-1178631019839010"></xref>–<xref ref-type="bibr" rid="bibr8-1178631019839010">8</xref></sup> Briefly, exomes were captured using the Agilent SureSelect Human All Exon V5 enrichment kit and multiplex sequenced (6-plex) on an Illumina HiSeq 2500 platform to reach about 100-fold coverage on average and were mapped according to the human reference genome build 38. Variants were filtered based on allele frequency in ExAC and in the Lithuanian population, pathogenicity predictions scores (SIFT, PolyPhen, MutationTaster, CADD),<sup><xref ref-type="bibr" rid="bibr9-1178631019839010">9</xref><xref ref-type="bibr" rid="bibr10-1178631019839010"></xref><xref ref-type="bibr" rid="bibr11-1178631019839010"></xref><xref ref-type="bibr" rid="bibr12-1178631019839010"></xref>–<xref ref-type="bibr" rid="bibr13-1178631019839010">13</xref></sup> and inheritance patterns including autosomal-recessive, X-linked, and <italic>de novo</italic>/autosomal dominant using the Varapp filtering software.<sup><xref ref-type="bibr" rid="bibr14-1178631019839010">14</xref></sup> Sanger sequencing confirmed the anticipated segregation of the potentially causative variant.</p>
</sec>
</sec>
<sec id="section4-1178631019839010" sec-type="results">
<title>Results</title>
<p>The proband (3 years 7 months old; <xref ref-type="fig" rid="fig1-1178631019839010">Figure 1A</xref> and <xref ref-type="fig" rid="fig1-1178631019839010">B</xref>) is the firstborn male child of healthy non-consanguineous parents. Family history was unremarkable, with no undue exposure to teratogens reported. The pregnancy was complicated by imminent preterm labour at 32 weeks of gestation. The patient was born at 34 weeks of gestation with the umbilical cord wrapped around his neck and green amniotic fluid. The propositus head circumference, weight, and length at birth were 34 cm (90th centile), 2275 g (50th centile), and 49 cm (90th centile), respectively. On delivery, his Apgar scores at 1 minute and 5 minutes were 8 and 8, respectively. He was apneic at birth and was intubated for several days. He also received nasogastric tube feeding to circumvent swallowing issues. A brain magnetic resonance imaging (<italic>MRI</italic>) examination performed at 1.5 months of age showed mildly hypoplastic inferior vermis, slight dilatation of the lateral ventricles, and dilated fourth ventricle (<xref ref-type="fig" rid="fig1-1178631019839010">Figure 1C</xref> and <xref ref-type="fig" rid="fig1-1178631019839010">D</xref>). Brain MRI examination has not revealed anomalies of olfactory bulb, optic nerves, or pituitary gland. At 4 months of age, a gastrostomy tube was placed. Multiple congenital birth defects were observed soon after birth. An echocardiogram identified a small atrial septal defect, while a brain ultrasonographic assessment revealed inferior <italic>vermian hypoplasia</italic>. Bilateral choroid coloboma involving the optic nerves was diagnosed by an ophthalmologist at 13 months. Surgical correction was performed for a congenital umbilical hernia and a congenital hernia at the <italic>linea alba</italic>. Bilateral sensorineural hearing loss was managed with hearing aids. Hypoglycemic episodes started to manifest at approximately 9 months of age, and therapy with slow release cornstarch was initiated. Notably, there has also been clear psychomotor delay as the proband could sit without support by 15 months of age and walk independently at 37 months of age. His first teeth erupted at 14 months of age. The boy has no expressive language. At 2 years 8 months old, his psychomotor development was evaluated to be in the range of 3 (self-help) <italic>to 10</italic> (fine motor) months according the Diagnostic Inventory for Screening Children (DISC) scale. In addition, he was diagnosed with autism spectrum disorder at 2 years 9 months of age. During his last examination, at the age of 3 years 7 months, his weight was 11.5 kg (&lt;3rd centile) and his height was 88 cm (&lt;3rd centile). He had a prominent metopic ridge, smaller and wide right ear, sacral dimple, clinodactyly of the 5th fingers, micropenis, and cryptorchidism. He was still suffering from laryngomalacia and severe feeding problems necessitating gastrostomy tube feeding. Frequent feeds and uncooked cornstarch every 6 hours was used to prevent hypoglycemic episodes. In summary, the proband presents with 3 major and 5 minor features of CHARGE syndrome (<xref ref-type="table" rid="table1-1178631019839010">Table 1</xref>) combined with additional features.</p>
<fig id="fig1-1178631019839010" orientation="portrait" position="float">
<label>Figure 1.</label>
<caption>
<p>(A) Front and (B) side views of the patient at 1 year and 9 months of age. Brain MRI at 1.5 months of age showed (C) slight dilatation of the lateral ventricles, mildly hypoplastic inferior vermis and (D) dilated fourth ventricle. (E) An electropherogram of the genomic DNA sequence of the patient showed a <italic>de novo</italic> duplication in <italic>CHD7</italic>: c.6341_6358dup (Asp2119_Pro2120ins6) A mutated sequence with duplication in red written beneath. (F) Alignment of CHD7 protein fragment for 9 different placental mammal species confirmed that the Asp2119_Pro2120ins6 non-frameshift insertion affects an evolutionary conserved region. Secondary structures of the peptide encoded by the wild type (left) and Asp2119_Pro2120ins6 mutated (right) exon 31 of CHD7 are shown as rainbow ribbons. (G) The new short alpha helix that is formed by the inserted amino acid residues is in yellow. Models of wild-type and mutated protein structure were formed using SWISS-MODEL software.<sup><xref ref-type="bibr" rid="bibr15-1178631019839010">15</xref></sup> MRI indicates magnetic resonance imaging.</p>
</caption>
<graphic xlink:href="10.1177_1178631019839010-fig1"></graphic>
</fig>
<p>As no cytogenetic alterations were identified, we assessed the genome of the proband and his parents by WES. We identified a <italic>de novo</italic> 18 nucleotides duplication in exon 31 of the <italic>CHD7</italic> gene (c.6341_6358dup, p.Asp2119_Pro2120ins6); NM_017780; NP_060250; MIM 214800) confirmed by Sanger sequencing (<xref ref-type="fig" rid="fig1-1178631019839010">Figure 1E</xref>), which affects an evolutionary constrained region (<xref ref-type="fig" rid="fig1-1178631019839010">Figure 1F</xref>). Modelization of the putatively encoded mutated protein suggests that the insertion of this chain of 6 amino acid residues potentially substitutes a linear chain into a short alpha helix (<xref ref-type="fig" rid="fig1-1178631019839010">Figure 1G</xref>). The other deleterious <italic>de novo</italic> variants, which contribute to the current patient phenotype, were not identified. All unique <italic>de novo</italic> variants identified for this proband are listed in <xref ref-type="table" rid="table2-1178631019839010">Table 2</xref>.</p>
<table-wrap id="table2-1178631019839010" orientation="portrait" position="float">
<label>Table 2.</label>
<caption>
<p>List of <italic>de novo</italic> variants identified for the proband.</p>
</caption>
<alternatives>
<graphic xlink:href="10.1177_1178631019839010-table2"></graphic>
<table frame="hsides" rules="groups">
<colgroup span="1">
<col align="left" span="1"/>
<col align="char" char="." span="1"/>
<col align="char" char="." span="1"/>
<col align="char" char="." span="1"/>
<col align="char" char="." span="1"/>
<col align="char" char="." span="1"/>
<col align="char" char="." span="1"/>
<col align="char" char="." span="1"/>
</colgroup>
<thead>
<tr>
<th align="left" colspan="1" rowspan="1">Chromosome</th>
<th align="left" colspan="1" rowspan="1">Start</th>
<th align="left" colspan="1" rowspan="1">Reference allele</th>
<th align="left" colspan="1" rowspan="1">Alternative allele</th>
<th align="left" colspan="1" rowspan="1">Gene symbol</th>
<th align="left" colspan="1" rowspan="1">Aa change</th>
<th align="left" colspan="1" rowspan="1">Impact</th>
<th align="left" colspan="1" rowspan="1">Genotype</th>
</tr>
</thead>
<tbody>
<tr>
<td colspan="1" rowspan="1">
<bold>chr20</bold>
</td>
<td colspan="1" rowspan="1">52557934</td>
<td colspan="1" rowspan="1">GGT</td>
<td colspan="1" rowspan="1">G</td>
<td colspan="1" rowspan="1">
<italic>AC005220.3</italic>
</td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1">Splice donor variant</td>
<td colspan="1" rowspan="1">Heterozygous</td>
</tr>
<tr>
<td colspan="1" rowspan="1">
<bold>chr7</bold>
</td>
<td colspan="1" rowspan="1">150811966</td>
<td colspan="1" rowspan="1">G</td>
<td colspan="1" rowspan="1">A</td>
<td colspan="1" rowspan="1">
<italic>AGAP3</italic>
</td>
<td colspan="1" rowspan="1">G/S</td>
<td colspan="1" rowspan="1">Missense variant</td>
<td colspan="1" rowspan="1">Heterozygous</td>
</tr>
<tr>
<td colspan="1" rowspan="1">
<bold>chr7</bold>
</td>
<td colspan="1" rowspan="1">150811967</td>
<td colspan="1" rowspan="1">G</td>
<td colspan="1" rowspan="1">A</td>
<td colspan="1" rowspan="1">
<italic>AGAP3</italic>
</td>
<td colspan="1" rowspan="1">G/D</td>
<td colspan="1" rowspan="1">Missense variant</td>
<td colspan="1" rowspan="1">Heterozygous</td>
</tr>
<tr>
<td colspan="1" rowspan="1">
<bold>chr11</bold>
</td>
<td colspan="1" rowspan="1">13435092</td>
<td colspan="1" rowspan="1">T</td>
<td colspan="1" rowspan="1">G</td>
<td colspan="1" rowspan="1">
<italic>BTBD10</italic>
</td>
<td colspan="1" rowspan="1">K/Q</td>
<td colspan="1" rowspan="1">Missense variant</td>
<td colspan="1" rowspan="1">Heterozygous</td>
</tr>
<tr>
<td colspan="1" rowspan="1">
<bold>chr11</bold>
</td>
<td colspan="1" rowspan="1">66512290</td>
<td colspan="1" rowspan="1">G</td>
<td colspan="1" rowspan="1">GGGCGGCGGCGGC</td>
<td colspan="1" rowspan="1">
<italic>C11orf80</italic>
</td>
<td colspan="1" rowspan="1">G/GAAAA</td>
<td colspan="1" rowspan="1">Inframe insertion</td>
<td colspan="1" rowspan="1">Heterozygous</td>
</tr>
<tr>
<td colspan="1" rowspan="1">
<bold>chr2</bold>
</td>
<td colspan="1" rowspan="1">153476066</td>
<td colspan="1" rowspan="1">G</td>
<td colspan="1" rowspan="1">GCCACCCCCCCCCCCA</td>
<td colspan="1" rowspan="1">
<italic>FMNL2</italic>
</td>
<td colspan="1" rowspan="1">−/PPPPP</td>
<td colspan="1" rowspan="1">Inframe insertion</td>
<td colspan="1" rowspan="1">Heterozygous</td>
</tr>
<tr>
<td colspan="1" rowspan="1">
<bold>chr6</bold>
</td>
<td colspan="1" rowspan="1">30996720</td>
<td colspan="1" rowspan="1">C</td>
<td colspan="1" rowspan="1">CAGGCTCTGAGACCACCACAGCCTCTACTGA</td>
<td colspan="1" rowspan="1">
<italic>MUC22</italic>
</td>
<td colspan="1" rowspan="1">T/TGSETTTASTE</td>
<td colspan="1" rowspan="1">Inframe insertion</td>
<td colspan="1" rowspan="1">Heterozygous</td>
</tr>
<tr>
<td colspan="1" rowspan="1">
<bold>chr19</bold>
</td>
<td colspan="1" rowspan="1">2015540</td>
<td colspan="1" rowspan="1">GGGCGGCGGCGGC</td>
<td colspan="1" rowspan="1">G</td>
<td colspan="1" rowspan="1">
<italic>BTBD2</italic>
</td>
<td colspan="1" rowspan="1">AAAA/−</td>
<td colspan="1" rowspan="1">Inframe deletion</td>
<td colspan="1" rowspan="1">Homozygous</td>
</tr>
<tr>
<td colspan="1" rowspan="1">
<bold>chr3</bold>
</td>
<td colspan="1" rowspan="1">42251577</td>
<td colspan="1" rowspan="1">C</td>
<td colspan="1" rowspan="1">CGGA</td>
<td colspan="1" rowspan="1">
<italic>TRAK1</italic>
</td>
<td colspan="1" rowspan="1">T/TE</td>
<td colspan="1" rowspan="1">Inframe insertion</td>
<td colspan="1" rowspan="1">Heterozygous</td>
</tr>
<tr>
<td colspan="1" rowspan="1">
<bold>chr14</bold>
</td>
<td colspan="1" rowspan="1">73874252</td>
<td colspan="1" rowspan="1">G</td>
<td colspan="1" rowspan="1">–</td>
<td colspan="1" rowspan="1">
<italic>PTGR2</italic>
</td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1">NA</td>
<td colspan="1" rowspan="1">Heterozygous</td>
</tr>
<tr>
<td colspan="1" rowspan="1">
<bold>chr4</bold>
</td>
<td colspan="1" rowspan="1">87615711</td>
<td colspan="1" rowspan="1">AATAGTAGTGACAGCAGC</td>
<td colspan="1" rowspan="1">–</td>
<td colspan="1" rowspan="1">
<italic>DSPP</italic>
</td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1">Non-frameshift deletion</td>
<td colspan="1" rowspan="1">Heterozygous</td>
</tr>
<tr>
<td colspan="1" rowspan="1">
<bold>chr8</bold>
</td>
<td colspan="1" rowspan="1">60853065</td>
<td colspan="1" rowspan="1">–</td>
<td colspan="1" rowspan="1">ATCACATCCTCAATGACC</td>
<td colspan="1" rowspan="1">
<italic>CHD7</italic>
</td>
<td colspan="1" rowspan="1">−/HILNDH</td>
<td colspan="1" rowspan="1">Non-frameshift insertion</td>
<td colspan="1" rowspan="1">Heterozygous</td>
</tr>
</tbody>
</table>
</alternatives>
<table-wrap-foot>
<fn id="table-fn2-1178631019839010">
<p><italic>De novo</italic> variant in <italic>CHD7</italic> gene associated with CHARGE syndrome is marked in grey.</p>
</fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="section5-1178631019839010" sec-type="discussion">
<title>Discussion</title>
<p>Alterations in <italic>CHD7</italic> have been identified in more than two-third of all children, who fulfil the clinical diagnostic criteria for CHARGE syndrome.<sup><xref ref-type="bibr" rid="bibr16-1178631019839010">16</xref><xref ref-type="bibr" rid="bibr17-1178631019839010"></xref>–<xref ref-type="bibr" rid="bibr18-1178631019839010">18</xref></sup> Truncating variants including nonsense, frameshift, and splice variants (89%) that typically result in haploinsufficiency are the most frequently encountered followed by missense (8%) variants.<sup><xref ref-type="bibr" rid="bibr17-1178631019839010">17</xref>,<xref ref-type="bibr" rid="bibr19-1178631019839010">19</xref>,<xref ref-type="bibr" rid="bibr20-1178631019839010">20</xref></sup>
<italic>CHD7</italic> encodes a chromodomain helicase DNA-binding protein, which plays a significant role in early embryonic development and controls gene expression via chromatin remodelling during the cell cycle.<sup><xref ref-type="bibr" rid="bibr21-1178631019839010">21</xref></sup></p>
<p>Besides the duplication described here, other variants affecting the same region in the protein have been identified, for example, the <italic>de novo</italic> missense variant c.6347T&gt;A; p.Ile2116Asn (CM090041) that changes a hydrophobic into a polar amino acid. The associated patient presented with a milder pheno-type than our proband characterized by cleft palate, auricular dysplasia, nystagmus, bilateral perceptive deafness, and semi-circular canal hypoplasia.<sup><xref ref-type="bibr" rid="bibr22-1178631019839010">22</xref></sup> Similarly, the c.6322G&gt;A; p.Gly2108Arg (CM080142) missense variant has been detected in 3 patients with mild CHARGE syndrome features, which include unilateral optic nerve coloboma and microphthalmia, bilateral sensorineural deafness, dysmorphic ears, hypoplastic semicircular canals, and bifid uvula.<sup><xref ref-type="bibr" rid="bibr23-1178631019839010">23</xref></sup> The association between the insertion of the HILNDH peptide and a severe phenotype is not surprising as it is predicted to form a novel alpha helix within a highly conserved region of the protein.</p>
<p>While additional work is necessary to understand this complex disease, this study further expands the understanding of CHARGE syndrome pathogenesis and suggests that severe CHARGE syndrome phenotypes can be caused by deletions, point mutations,<sup><xref ref-type="bibr" rid="bibr17-1178631019839010">17</xref></sup> and duplications/insertions.</p>
</sec>
</body>
<back>
<ack>
<p>We extend our sincere appreciation to the patient’s family for their support.</p>
</ack>
<fn-group>
<fn fn-type="financial-disclosure">
<p><bold>Funding:</bold>The author(s) disclosed receipt of the following financial support for the research, authorship and/or publication of this article: This study was supported by the Lithuanian-Swiss Cooperation Programme under UNIGENE project agreement no. CH-3-ŠMM-01/04 and a grant from the Swiss National Science Foundation (31003A_160203) to AR.</p>
</fn>
<fn fn-type="COI-statement">
<p><bold>Declaration of conflicting interests:</bold>The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.</p>
</fn>
<fn fn-type="con">
<p><bold>Author Contributions:</bold> LP performed data analysis. LP and EP prepared the manuscript. Sequencing of trios exomes was performed by LG. AR and VK contributed to conception and design and critically revised the manuscript.</p>
</fn>
<fn fn-type="other">
<p><bold>Ethical Approval:</bold> The patient’s parents provided written informed consent to publish all clinical information, including photographs of the patient.</p>
</fn>
</fn-group>
<ref-list>
<title>References</title>
<ref id="bibr1-1178631019839010">
<label>1</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Issekutz</surname><given-names>KA</given-names></name><name><surname>Graham</surname><given-names>JM</given-names><suffix>Jr</suffix></name><name><surname>Prasad</surname><given-names>C</given-names></name><name><surname>Smith</surname><given-names>IM</given-names></name><name><surname>Blake</surname><given-names>KD.</given-names></name></person-group>
<article-title>An epidemiological analysis of CHARGE syndrome: preliminary results from a Canadian study</article-title>. <source/>Am J Med Genet A. <year>2005</year>;<volume>133A</volume>:<fpage>309</fpage>–<lpage>317</lpage>.<pub-id pub-id-type="pmid">15637722</pub-id></mixed-citation>
</ref>
<ref id="bibr2-1178631019839010">
<label>2</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Blake</surname><given-names>K</given-names></name><name><surname>MacCuspie</surname><given-names>J</given-names></name><name><surname>Hartshorne</surname><given-names>TS</given-names></name><name><surname>Roy</surname><given-names>M</given-names></name><name><surname>Davenport</surname><given-names>SL</given-names></name><name><surname>Corsten</surname><given-names>G.</given-names></name></person-group>
<article-title>Postoperative airway events of individuals with CHARGE syndrome</article-title>. <source/>Int J Pediatr Otorhinolaryngol. <year>2009</year>;<volume>73</volume>:<fpage>219</fpage>–<lpage>226</lpage>.<pub-id pub-id-type="pmid">19058860</pub-id></mixed-citation>
</ref>
<ref id="bibr3-1178631019839010">
<label>3</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Vuorela</surname><given-names>PE</given-names></name><name><surname>Penttinen</surname><given-names>MT</given-names></name><name><surname>Hietala</surname><given-names>MH</given-names></name><name><surname>Laine</surname><given-names>JO</given-names></name><name><surname>Huoponen</surname><given-names>KA</given-names></name><name><surname>Kääriäinen</surname><given-names>HA.</given-names></name></person-group>
<article-title>A familial CHARGE syndrome with a CHD7 nonsense mutation and new clinical features</article-title>. <source/>Clin Dysmorphol. <year>2008</year>;<volume>17</volume>:<fpage>249</fpage>–<lpage>253</lpage>.<pub-id pub-id-type="pmid">18978652</pub-id></mixed-citation>
</ref>
<ref id="bibr4-1178631019839010">
<label>4</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Borck</surname><given-names>G</given-names></name><name><surname>Hög</surname><given-names>F</given-names></name><name><surname>Dentici</surname><given-names>ML</given-names></name><etal>et al</etal></person-group>
<article-title>BRF1 mutations alter RNA polymerase III-dependent transcription and cause neurodevelopmental anomalies</article-title>. <source/>Genome Res. <year>2015</year>;<volume>25</volume>:<fpage>155</fpage>–<lpage>166</lpage>.<pub-id pub-id-type="pmid">25561519</pub-id></mixed-citation>
</ref>
<ref id="bibr5-1178631019839010">
<label>5</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Alfaiz</surname><given-names>AA</given-names></name><name><surname>Micale</surname><given-names>L</given-names></name><name><surname>Mandriani</surname><given-names>B</given-names></name><etal>et al</etal></person-group>
<article-title>TBC1D7 mutations are associated with intellectual disability, macrocrania, patellar dislocation, and celiac disease</article-title>. <source/>Hum Mutat. <year>2014</year>;<volume>35</volume>:<fpage>447</fpage>–<lpage>451</lpage>.<pub-id pub-id-type="pmid">24515783</pub-id></mixed-citation>
</ref>
<ref id="bibr6-1178631019839010">
<label>6</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Lodder</surname><given-names>EM</given-names></name><name><surname>De Nittis</surname><given-names>P</given-names></name><name><surname>Koopman</surname><given-names>CD</given-names></name><etal>et al</etal></person-group>
<article-title>GNB5 mutations cause an autosomal-recessive multisystem syndrome with sinus bradycardia and cognitive disability</article-title>. <source/>Am J Hum Genet. <year>2016</year>;<volume>99</volume>:<fpage>704</fpage>–<lpage>710</lpage>.<pub-id pub-id-type="pmid">27523599</pub-id></mixed-citation>
</ref>
<ref id="bibr7-1178631019839010">
<label>7</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Tumienė</surname><given-names>B</given-names></name><name><surname>Voisin</surname><given-names>N</given-names></name><name><surname>Preikšaitienė</surname><given-names>E</given-names></name><etal>et al</etal></person-group>
<article-title>Inflammatory myopathy in a patient with Aicardi-Goutières syndrome</article-title>. <source/>Eur J Med Genet. <year>2017</year>;<volume>60</volume>:<fpage>154</fpage>–<lpage>158</lpage>.<pub-id pub-id-type="pmid">28089741</pub-id></mixed-citation>
</ref>
<ref id="bibr8-1178631019839010">
<label>8</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Gueneau</surname><given-names>L</given-names></name><name><surname>Fish</surname><given-names>R</given-names></name><name><surname>Shamseddin</surname><given-names>HE</given-names></name><etal>et al</etal></person-group>
<article-title>KIAA1109 variants are associated with a severe disorder of brain development and arthrogryposis</article-title>. <source/>Am J Hum Genet. <year>2018</year>;<volume>102</volume>:<fpage>116</fpage>–<lpage>132</lpage>.<pub-id pub-id-type="pmid">29290337</pub-id></mixed-citation>
</ref>
<ref id="bibr9-1178631019839010">
<label>9</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Petrovski</surname><given-names>S</given-names></name><name><surname>Wang</surname><given-names>QL</given-names></name><name><surname>Heinzen</surname><given-names>EL</given-names></name><name><surname>Allen</surname><given-names>AS</given-names></name><name><surname>Goldstein</surname><given-names>DB.</given-names></name></person-group>
<article-title>Genic intolerance to functional variation and the interpretation of personal genomes</article-title>. <source/>PLoS Genet. <year>2013</year>;<volume>9</volume>:<fpage>e1003709</fpage>.<pub-id pub-id-type="pmid">23990802</pub-id></mixed-citation>
</ref>
<ref id="bibr10-1178631019839010">
<label>10</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Schwarz</surname><given-names>JM</given-names></name><name><surname>Rödelsperger</surname><given-names>C</given-names></name><name><surname>Schuelke</surname><given-names>M</given-names></name><name><surname>Seelow</surname><given-names>D.</given-names></name></person-group>
<article-title>MutationTaster evaluates disease-causing potential of sequence alterations</article-title>. <source/>Nat Methods. <year>2010</year>;<volume>7</volume>:<fpage>575</fpage>–<lpage>576</lpage>.<pub-id pub-id-type="pmid">20676075</pub-id></mixed-citation>
</ref>
<ref id="bibr11-1178631019839010">
<label>11</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ng</surname><given-names>PC</given-names></name><name><surname>Henikoff</surname><given-names>S.</given-names></name></person-group>
<article-title>Predicting deleterious amino acid substitutions</article-title>. <source/>Genome Res. <year>2001</year>;<volume>11</volume>:<fpage>863</fpage>–<lpage>874</lpage>.<pub-id pub-id-type="pmid">11337480</pub-id></mixed-citation>
</ref>
<ref id="bibr12-1178631019839010">
<label>12</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Adzhubei</surname><given-names>IA</given-names></name><name><surname>Schmidt</surname><given-names>S</given-names></name><name><surname>Peshkin</surname><given-names>L</given-names></name><etal>et al</etal></person-group>
<article-title>A method and server for predicting damaging missense mutations</article-title>. <source/>Nat Methods. <year>2010</year>;<volume>7</volume>:<fpage>248</fpage>–<lpage>249</lpage>.<pub-id pub-id-type="pmid">20354512</pub-id></mixed-citation>
</ref>
<ref id="bibr13-1178631019839010">
<label>13</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Lek</surname><given-names>M</given-names></name><name><surname>Karczewski</surname><given-names>KJ</given-names></name><name><surname>Minikel</surname><given-names>EV</given-names></name><etal>et al</etal></person-group>
<article-title>Analysis of protein-coding genetic variation in 60,706 humans</article-title>. <source/>Nature. <year>2016</year>;<volume>536</volume>:<fpage>285</fpage>–<lpage>291</lpage>.<pub-id pub-id-type="pmid">27535533</pub-id></mixed-citation>
</ref>
<ref id="bibr14-1178631019839010">
<label>14</label>
<mixed-citation publication-type="web">
<person-group person-group-type="author"><name><surname>Delafontaine</surname><given-names>J</given-names></name><name><surname>Masselot</surname><given-names>A</given-names></name><name><surname>Liechti</surname><given-names>R</given-names></name><name><surname>Kuznetsov</surname><given-names>D</given-names></name><name><surname>Xenarios</surname><given-names>I</given-names></name><name><surname>Pradervand</surname><given-names>S</given-names></name></person-group>
<article-title>Varapp: a reactive web-application for variants filtering</article-title> [published online ahead of print June 28, 2016]. <source/>bioRxiv. doi:<pub-id pub-id-type="doi">10.1101/060806</pub-id>.</mixed-citation>
</ref>
<ref id="bibr15-1178631019839010">
<label>15</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Biasini</surname><given-names>M</given-names></name><name><surname>Bienert</surname><given-names>S</given-names></name><name><surname>Waterhouse</surname><given-names>A</given-names></name><etal>et al</etal></person-group>
<article-title>SWISS-MODEL: modelling protein tertiary and quaternary structure using evolutionary information</article-title>. <source/>Nucleic Acids Res. <year>2014</year>;<volume>42</volume>:<fpage>W252</fpage>–<lpage>W258</lpage>.<pub-id pub-id-type="pmid">24782522</pub-id></mixed-citation>
</ref>
<ref id="bibr16-1178631019839010">
<label>16</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Bergman</surname><given-names>JE</given-names></name><name><surname>Janssen</surname><given-names>N</given-names></name><name><surname>Hoefsloot</surname><given-names>LH</given-names></name><name><surname>Jongmans</surname><given-names>MC</given-names></name><name><surname>Hofstra</surname><given-names>RM</given-names></name><name><surname>van Ravenswaaij-Arts</surname><given-names>CM.</given-names></name></person-group>
<article-title>CHD7 mutations and CHARGE syndrome: the clinical implications of an expanding phenotype</article-title>. <source/>J Med Genet. <year>2011</year>;<volume>48</volume>:<fpage>334</fpage>–<lpage>342</lpage>.<pub-id pub-id-type="pmid">21378379</pub-id></mixed-citation>
</ref>
<ref id="bibr17-1178631019839010">
<label>17</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Katoh-Fukui</surname><given-names>Y</given-names></name><name><surname>Yatsuga</surname><given-names>S</given-names></name><name><surname>Shima</surname><given-names>H</given-names></name><etal>et al</etal></person-group>
<article-title>An unclassified variant of CHD7 activates a cryptic splice site in a patient with CHARGE syndrome</article-title>. <source/>Hum Genome Var. <year>2018</year>;<volume>5</volume>:<fpage>18006</fpage>.<pub-id pub-id-type="pmid">29531775</pub-id></mixed-citation>
</ref>
<ref id="bibr18-1178631019839010">
<label>18</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Martin</surname><given-names>DM.</given-names></name></person-group>
<article-title>Epigenetic developmental disorders: CHARGE syndrome, a case study</article-title>. <source/>Curr Genet Med Rep. <year>2015</year>;<volume>3</volume>:<fpage>1</fpage>–<lpage>7</lpage>.<pub-id pub-id-type="pmid">25685640</pub-id></mixed-citation>
</ref>
<ref id="bibr19-1178631019839010">
<label>19</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Vissers</surname><given-names>LE</given-names></name><name><surname>van Ravenswaaij</surname><given-names>CM</given-names></name><name><surname>Admiraal</surname><given-names>R</given-names></name><etal>et al</etal></person-group>
<article-title>Mutations in a new member of the chromodomain gene family cause CHARGE syndrome</article-title>. <source/>Nat Genet. <year>2004</year>;<volume>36</volume>:<fpage>955</fpage>–<lpage>957</lpage>.<pub-id pub-id-type="pmid">15300250</pub-id></mixed-citation>
</ref>
<ref id="bibr20-1178631019839010">
<label>20</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Zentner</surname><given-names>GE</given-names></name><name><surname>Layman</surname><given-names>WS</given-names></name><name><surname>Martin</surname><given-names>DM</given-names></name><name><surname>Scacheri</surname><given-names>PC.</given-names></name></person-group>
<article-title>Molecular and phenotypic aspects of CHD7 mutation in CHARGE syndrome</article-title>. <source/>Am J Med Genet A. <year>2010</year>;<volume>152A</volume>:<fpage>674</fpage>–<lpage>686</lpage>.<pub-id pub-id-type="pmid">20186815</pub-id></mixed-citation>
</ref>
<ref id="bibr21-1178631019839010">
<label>21</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Sanlaville</surname><given-names>D</given-names></name><name><surname>Etchevers</surname><given-names>HC</given-names></name><name><surname>Gonzales</surname><given-names>M</given-names></name><etal>et al</etal></person-group>
<article-title>Phenotypic spectrum of CHARGE syndrome in fetuses with CHD7 truncating mutations correlates with expression during human development</article-title>. <source/>J Med Genet. <year>2006</year>;<volume>43</volume>:<fpage>211</fpage>–<lpage>217</lpage>.<pub-id pub-id-type="pmid">16169932</pub-id></mixed-citation>
</ref>
<ref id="bibr22-1178631019839010">
<label>22</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Jongmans</surname><given-names>MC</given-names></name><name><surname>van Ravenswaaij-Arts</surname><given-names>CM</given-names></name><name><surname>Pitteloud</surname><given-names>N</given-names></name><etal>et al</etal></person-group>
<article-title>CHD7 mutations in patients initially diagnosed with Kallmann syndrome – the clinical overlap with CHARGE syndrome</article-title>. <source/>Clin Genet. <year>2009</year>;<volume>75</volume>:<fpage>65</fpage>–<lpage>71</lpage>.<pub-id pub-id-type="pmid">19021638</pub-id></mixed-citation>
</ref>
<ref id="bibr23-1178631019839010">
<label>23</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Jongmans</surname><given-names>MC</given-names></name><name><surname>Hoefsloot</surname><given-names>LH</given-names></name><name><surname>van der Donk</surname><given-names>KP</given-names></name><etal>et al</etal></person-group>
<article-title>Familial CHARGE syndrome and the CHD7 gene: a recurrent missense mutation, intrafamilial recurrence and variability</article-title>. <source/>Am J Med Genet A. <year>2008</year>;<volume>146A</volume>:<fpage>43</fpage>–<lpage>50</lpage>.<pub-id pub-id-type="pmid">18074359</pub-id></mixed-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>